Gun Laws and Medical Cannabis in Kentucky
At The Post Dispensary in Beaver Dam, we support Kentucky’s medical cannabis patients with accurate, up-to-date information. Kentucky’s program, launched in January 2025 under Senate Bill 47, provides regulated access for residents with qualifying conditions. This article outlines the current relationship between state medical cannabis rules and federal/state gun laws as of May 2026. It is for educational purposes only and is not legal advice.
Kentucky’s Medical Cannabis Program
Kentucky’s medical cannabis program is overseen by the Office of Medical Cannabis. Qualified patients must be Kentucky residents, obtain a written certification from an authorized practitioner for approved debilitating conditions (such as cancer, epilepsy, PTSD, multiple sclerosis, or severe chronic pain), and register for a medical cannabis card. As of early 2026, over 20,000 patients hold active cards. Products are available only from licensed dispensaries like The Post, with strict testing, tracking, and possession limits in place under KRS Chapter 218B.
Federal Firearms Restrictions and Cannabis
Federal law creates the main point of tension. Under the Gun Control Act of 1968, it is unlawful for any “unlawful user of or addicted to any controlled substance” to possess or receive firearms or ammunition. Marijuana remains a federally controlled substance, and the Bureau of Alcohol, Tobacco, Firearms and Explosives (ATF) has long viewed individuals who use marijuana as unlawful users.
When buying a firearm from a Federal Firearms Licensee (FFL), individuals must complete ATF Form 4473. Question 11(e) specifically addresses marijuana use, with a warning that it remains illegal under federal law even if authorized by a state medical program. Answering falsely is a federal offense. ATF guidance instructs FFLs not to transfer firearms to known marijuana users, including medical cannabis cardholders.
Kentucky’s Approach to Gun Laws
Kentucky maintains some of the most permissive gun laws in the nation. Constitutional carry allows eligible adults (generally age 21 and older, not otherwise prohibited) to carry concealed handguns without a permit, and open carry is broadly allowed. The state does not impose additional firearm restrictions specifically targeting medical cannabis patients.
Pending Supreme Court Case: United States v. Hemani
A key development is the ongoing Supreme Court case United States v. Hemani, which directly challenges the application of 18 U.S.C. § 922(g)(3) to marijuana users. The case involves a Texas man charged after authorities found a firearm and marijuana in his home; he admitted to regular marijuana use. Lower courts, including the Fifth Circuit, ruled that the federal ban violated the Second Amendment when applied to someone not actively intoxicated at the time of possession. The Supreme Court heard oral arguments on March 2, 2026. Many justices expressed skepticism about the government’s position, questioning whether the categorical ban aligns with historical firearm regulations under the framework established in prior Second Amendment cases. A decision is expected by summer 2026. The outcome could have significant implications for medical cannabis patients nationwide, including in Kentucky, by potentially narrowing or clarifying the federal prohibition.
Recent Federal Rescheduling Developments
In April 2026, the DEA placed certain FDA-approved and state-regulated medical marijuana products into Schedule III of the Controlled Substances Act. This partial rescheduling recognizes medical use for regulated products and provides benefits to the cannabis industry, such as improved tax treatment under IRC Section 280E and better banking access for licensed businesses.
A broader rescheduling process continues with ongoing hearings. While these changes mark important progress for Kentucky’s medical cannabis program—potentially strengthening the industry and research opportunities—they have not altered the federal firearms prohibition. As of May 2026, the ATF Form 4473 and related guidance remain unchanged for medical cannabis users. The Department of Justice has stated in court proceedings that rescheduling does not resolve the gun ban issue for marijuana users. Legal challenges focusing on Second Amendment questions are still pending.
Update (as of May 2026): Proposed Revision to ATF Form 4473
In a significant development following the April 2026 rescheduling of certain FDA-approved and state-regulated medical marijuana products to Schedule III of the Controlled Substances Act, the Bureau of Alcohol, Tobacco, Firearms and Explosives (ATF) posted a proposed revised version of ATF Form 4473 on May 8, 2026. The draft form updates the language in the controlled substance question and warning to reflect the new federal status of medical cannabis. Under the proposed revision, firearm purchasers would attest to the following:
“I am not an unlawful user of, or addicted to, marijuana or any depressant, stimulant, narcotic drug, or any other controlled substance.” The accompanying warning would read: “(Warning: You can be an unlawful user under federal law, even if your possession is legal under state law. Federal law does not permit the use or possession of marijuana for recreational purposes.)”
This change removes the prior explicit reference to medical cannabis that had previously stated marijuana use or possession remains unlawful under federal law “regardless of whether it has been legalized or decriminalized for medicinal or recreational purposes in the state where you reside.” The proposed update acknowledges that state-authorized medical cannabis products are no longer treated as Schedule I substances for certain regulatory purposes. The revised form is currently open for public comment through July 7, 2026, and is not yet finalized or in mandatory use. Kentucky patients and firearms dealers should continue consulting the most current official ATF guidance, as enforcement positions and final form language may evolve.
Practical Considerations for Patients
Kentucky patients currently face a federal-state conflict: state law authorizes medical cannabis use, while federal law restricts firearm possession for those users. State lawmakers have introduced resolutions encouraging Congress to create exemptions for participants in state medical programs, and Governor Beshear has voiced support for protecting patient rights.
Rescheduling may eventually lead to clearer federal policies or congressional action, but it has not yet removed the federal restrictions. Patients should monitor official updates from the Kentucky Office of Medical Cannabis, the ATF, and the DEA.
Moving Forward
The intersection of gun laws and medical cannabis highlights the ongoing complexities of U.S. cannabis policy. Kentucky’s program offers meaningful medical relief to thousands, yet federal rules continue to influence areas like firearm ownership. At The Post Dispensary, we remain committed to transparency and patient support as the landscape evolves.For the most current details, visit kymedcan.ky.gov or consult official federal resources. Laws can change, so always refer to primary sources for the latest information.
Thank you for trusting The Post Dispensary as part of your health journey.
